Evaluating a nutritional screening tool for patients with inflammatory bowel disease
Official title: Diagnostic Performance of CONUT as a Nutritional Screening Tool in Patients With Inflammatory Bowel Disease
Run by Hospital General de Mexico · NCT06648551 · Data updated 2026-11-12
This study is testing a new nutritional screening tool to see if it can help identify nutritional deficiencies in people with inflammatory bowel disease.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years to 80 Years |
| Sex | All |
| Enrollment | 60 (estimated) |
| Sponsor | Hospital General de Mexico Government |
| Locations | 1 site (Mexico City, Cuauhtemoc) |
| Status | Recruiting |
| Started | October 28, 2023 |
| Main results expected | July 1, 2025 |
| Study ends | October 28, 2027 |
| Registry record updated | October 18, 2024 |
| Trial ID | NCT06648551 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates include adults aged 18 and older with histologically confirmed Ulcerative Colitis.
✕Probably not a fit
Patients with significant comorbidities, such as diabetes or heart failure, or those who are pregnant or lactating may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational study aims to assess the diagnostic performance of the Controlling Nutritional Status (CONUT) tool in patients diagnosed with Inflammatory Bowel Disease (IBD). Participants will undergo body composition analysis and a review of their medical history to evaluate their nutritional status using the GLIM criteria. The study will focus on determining the sensitivity and specificity of CONUT as a screening tool for nutritional deficiencies in this patient population.
Why it matters
Potential benefit: If successful, this study could improve nutritional screening and management for patients with inflammatory bowel disease.
How similar studies have gone: While the specific use of CONUT in IBD is novel, similar nutritional screening tools have shown promise in other patient populations.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Age 18 years and older * Gender unspecified * Histologically confirmed Ulcerative Colitis * Diagnosis confirmed by a specialist physician Exclusion Criteria: * Patients with any amputation or prosthesis * Patients with a pacemaker * Patients with any neoplasm * Pregnancy or lactation * With comorbidities such as diabetes, hypertension, heart failure, thyroid problems
Where it's running
-
Nallely Hernandez Bueno
Mexico City, Cuauhtemoc, Mexico Recruiting
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Dose-adjusted EPOCH infusions for frail adults with acute lymphoblastic leukemia
This project will see if a dose-adjusted, infusion-based EPOCH chemotherapy regimen helps frail adults with acute lymphoblastic leukemia tolerate treatment better and live longer.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.